好爽又高潮了毛片免费下载,国产97在线 | 亚洲,亚洲一区二区三区AV无码,特级AAAAAAAAA毛片免费视频

移動(dòng)端

Anti-NMP-22抗體,核基質(zhì)蛋白22抗體技術(shù)參數(shù)

2013年05月13日 15:25博研科研試劑網(wǎng)點(diǎn)擊量：794

博研科研試劑網(wǎng)*的實(shí)驗(yàn)室采購(gòu)專家，為您推薦：

                         

                         Anti-NMP-22抗體,核基質(zhì)蛋白22抗體技術(shù)參數(shù)
Catalog Number : BYK- 2451R
Quantity size : 0.1ml （dilute with pH 7.4 0.01 M PBS or antibody diluent ）
Background: Healthy individuals generally have very small amounts of NMP22 protein in the urine. However, the level of NMP22 protein is often elevated in the urine of patients with bladder cancer, even at early stages of the disease.1 The Alere NMP22 Test is an enzyme immunoassay for the quantitative determination of nuclear mitotic apparatus protein （NuMA） in stabilized voided urine. NuMA is an abundant component of the nuclear matrix proteins （NMP22）. The Alere NMP22?BladderChek?Test is the only in-office test approved by the FDA as an aid in the diagnosis and monitoring of bladder cancer in conjunction with standard diagnostic procedures. Both assays are painless and non-invasive and detect elevated levels of NMP22 protein.
Specificity :
–Anti- NMP-22 is a Rabbit polyclonal antibody unconjugated
–specific for NMP-22 of hu, mo, rat
–use for western blotting,elisa,immunoprecipitation and immunohistochemistry
–Protein G affinity chromatography purification, purity :>95%
–Isotype: IgG
–mol wt: 69kDa

Anti-NMP-22抗體,核基質(zhì)蛋白22抗體技術(shù)參數(shù)Application :
–Western blotting 1:100-500
–Immunohistochemistry 1:100-500
–ELISA 1:500-1000
–Optimal working dilutions must be determined by the end user.

Storage: Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody, the antibody is stable for at least six weeks at 2-4 ℃

Anti-NMP-22抗體,核基質(zhì)蛋白22抗體技術(shù)參數(shù)Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

版權(quán)與免責(zé)聲明： 凡本網(wǎng)注明“來源：智慧城市網(wǎng)”的所有作品，均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-智慧城市網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品，未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的，應(yīng)在授權(quán)范圍內(nèi)使用，并注明“來源：智慧城市網(wǎng)www.cmr6829.com”。違反上述聲明者，本網(wǎng)將追究其相關(guān)法律責(zé)任。

本網(wǎng)轉(zhuǎn)載并注明自其它來源（非智慧城市網(wǎng)www.cmr6829.com）的作品，目的在于傳遞更多信息，并不代表本網(wǎng)贊同其觀點(diǎn)或和對(duì)其真實(shí)性負(fù)責(zé)，不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí)，必須保留本網(wǎng)注明的作品第一來源，并自負(fù)版權(quán)等法律責(zé)任。

編輯精選

更多

本站精選

更多

專題推薦

更多

名企推薦

更多

浙公網(wǎng)安備 33010602000006號(hào)